Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $914.91 billion, total revenue of $172.71 billion and a weighted average PE ratio of 50.58.
Market Cap
914.91B
Revenue
172.71B
Profits
18.09B
PE Ratio
50.58
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 250.23B | 3.35% | 2,124,657 | 46.34B |
| 2 | DHR | Danaher Corporation | 155.51B | 3.34% | 3,093,907 | 25.11B |
| 3 | NTRA | Natera, Inc. | 61.35B | 3.73% | 2,021,832 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 48.29B | 2.09% | 1,768,932 | 7.37B |
| 5 | ILMN | Illumina, Inc. | 44.35B | 7.56% | 4,222,943 | 4.49B |
| 6 | IQV | IQVIA Holdings Inc. | 43.80B | 3.05% | 1,688,071 | 16.98B |
| 7 | WAT | Waters Corporation | 43.24B | 3.51% | 1,007,436 | 4.64B |
| 8 | IDXX | IDEXX Laboratories, Inc. | 41.52B | 1.67% | 588,919 | 4.55B |
| 9 | MTD | Mettler-Toledo International Inc. | 30.89B | 3.73% | 167,811 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.63B | -0.48% | 1,014,262 | 11.56B |
| 11 | GH | Guardant Health, Inc. | 25.12B | 5.30% | 1,746,285 | 1.18B |
| 12 | LH | Labcorp Holdings Inc. | 25.03B | 0.05% | 705,912 | 14.35B |
| 13 | RVTY | Revvity, Inc. | 17.56B | 3.85% | 1,551,387 | 2.91B |
| 14 | MEDP | Medpace Holdings, Inc. | 17.32B | 3.51% | 341,180 | 2.78B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.84B | 7.09% | 1,305,696 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.99B | 3.88% | 932,547 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.47B | 2.32% | 3,054,758 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.88B | 7.55% | 1,472,205 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.55B | 0.92% | 681,368 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.29B | 1.81% | 2,505,983 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 5.15B | 2.98% | 407,796 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.76B | 5.26% | 1,425,151 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.83B | 4.06% | 1,289,129 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.61B | 4.02% | 1,639,566 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.46B | 3.57% | 2,055,702 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.27B | 4.35% | 855,224 | 454.43M |
| 27 | FRNM | Freenome, Inc. | 1.81B | 3.12% | 772,774 | 35.41M |
| 28 | PSNL | Personalis, Inc. | 1.75B | 0.74% | 1,702,462 | 69.67M |
| 29 | OPK | OPKO Health, Inc. | 1.17B | 0.64% | 1,645,120 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.12B | 3.07% | 377,255 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 617.72M | 4.52% | 307,982 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 438.08M | 0.88% | 2,759,838 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 306.62M | 4.83% | 181,185 | 102.94M |
| 34 | XGN | Exagen Inc. | 204.95M | 3.55% | 291,763 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 166.90M | -2.62% | 49,051 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 120.10M | 6.69% | 408,366 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 113.49M | 1.50% | 274,879 | 537.08K |
| 38 | MDXH | MDxHealth SA | 56.95M | 4.54% | 126,205 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 42.96M | 3.76% | 43,475 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.47M | -5.79% | 15,081 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 9.46M | 4.13% | 29,555 | - |
| 42 | XWEL | XWELL, Inc. | 7.03M | -2.30% | 36,097 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.34M | 2.15% | 106,502 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.64M | -2.78% | 126,096 | 466.30K |